Using the streptozotocin-induced diabetic cardiomyopathy mouse model, Subramanian et al. demonstrated that the increase in fibrosis was significantly lower in OPN-/- versus WT mice, which was also associated with lower TGF-β levels [48]. This evidence concerns the gene SPP1 and diabetic cardiomyopathy.